Fortitude Family Office, LLC

Family Office

Position in AMRX — Amneal Pharmaceuticals, Inc.

CIK 1950506 SCOTTSDALE, AZ

Position in AMRX

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$13,848

+$4,327 QoQ

Shares Held

800

+4.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#250

of 305 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Fortitude Family Office, LLC holds $231,944 across 21 Drug Manufacturers - Specialty & Generic names. AMRX ranks #7 (6.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc	2,964	$47,068
2	UTHR	UNITED THERAPEUTICS Corp	64	$34,677
3	NBIX	Neurocrine Biosciences Inc	174	$29,325
4	LQDA	Liquidia Corp	327	$26,071
5	HIMS	Hims & Hers Health, Inc.	637	$22,084
6	KNSA	Kiniksa Pharmaceuticals International, plc	249	$15,923
7	AMRX	Amneal Pharmaceuticals, Inc. This page	800	$13,848
8	XERS	Xeris Biopharma Holdings, Inc.	1,500	$11,880

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$13,848	800	+4.4%	Shares	Sole	2026-07-20
2026-03-31	$9,521	766	-5.0%	Shares	Sole	2026-04-16
2025-12-31	$10,155	806	+2.9%	Shares	Sole	2026-01-15
2025-09-30	$7,837	783	-1.4%	Shares	Sole	2025-10-17
2025-06-30	$6,423	794	-17.8%	Shares	Sole	2025-07-15
2025-03-31	$8,095	966	0.0%	Shares	Sole	2025-04-16
2024-12-31	$7,650	966	0.0%	Shares	Sole	2025-01-10
2024-09-30	$8,037	966	0.0%	Shares	Sole	2024-10-25
2024-06-30	$6,134	966	0.0%	Shares	Sole	2024-07-10
2024-03-31	$5,853	966	0.0%	Shares	Sole	2024-04-11
2023-12-31	$5,863	966	—	Shares	Sole	2024-01-12
No filing history on record for this holder in this stock.